Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2022 09:27 ET | Source: American Battery Technology Company

American Battery Technology Company Announces Results of its Lithium-Bearing Tonopah Flats Exploration Drilling Phase 1 Program

Reno, Nev., June 21, 2022 (GLOBE NEWSWIRE) -- American Battery Technology Company,(ABTC) (OTCQB: ABML), an American critical battery materials company that is commercializing both its primary...
June 21, 2022 09:00 ET | Source: HOOKIPA Pharma Inc.

HOOKIPA Announces Executive Leadership Changes

NEW YORK and VIENNA, Austria, June 21, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary...
June 21, 2022 08:35 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech Secures New State-of-the-Art Facility for Product Development and Testing

OCALA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to...
June 21, 2022 08:30 ET | Source: Wall Street Reporter

CEO’s of NIO, NEXCF, MREO, and AIMLF Advancing Next Wave of Multi-Billion Dollar Growth Opportunities in Web 3.0, Wearables, Pharma, and Electric Vehicles.

NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of:NIO, Inc....
June 21, 2022 08:30 ET | Source: Teclison

Teclison Announces Publication of Phase 1 Data Demonstrating the Safety and Therapeutic Potential of Tirapazamine Chemoembolization for Patients with Unresectable Liver Cancer

— Tirapazamine (TPZ) with conventional trans-arterial chemoembolization had a good safety profile and promising efficacy signals in early- and intermediate-stage liver cancer, including in patients...
June 21, 2022 08:00 ET | Source: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release

NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
June 21, 2022 08:00 ET | Source: Celldex Therapeutics, Inc.

Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria

HAMPTON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been dosed in a Phase 2 clinical study of barzolvolimab for the...
June 21, 2022 08:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Reports Fiscal Year 2022 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, June 21, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage,...
June 21, 2022 08:00 ET | Source: Galectin Therapeutics Inc.

Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congress™ 2022

NORCROSS, Ga., June 21, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, announced today two scientific presentations...
June 21, 2022 07:30 ET | Source: Humacyte, Inc

Humacyte Provides Update on Patients Treated at Front-Line Hospitals in Ukraine with the Human Acellular Vessel™ (HAV™) for Repair of Vascular Trauma Injuries

-- Successful first two HAV implantations in wounded Ukrainian citizens -- HAVs were provided under Humacyte’s initiative to assist Ukraine humanitarian medical effort -- Provides further real-world...